🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

UPDATE 8-Oil hits highest since March on vaccine trials, Biden transition

Published 24/11/2020, 04:52
© Reuters.
AZN
-
LCO
-
CL
-
MRNA
-

* Biden transition given formal nod
* OPEC experts meet ahead of next week's ministerial
gathering
* U.S. crude stocks seen up 127,000 bbls last week - poll
* Coming Up: API inventory report at 4:30 p.m. ET/2130 GMT

(Updates prices and market activity; adds analyst comments,
U.S. inventory forecasts; changes byline, dateline, previous
LONDON)
By Laila Kearney
NEW YORK, Nov 24 (Reuters) - Oil rose more than $1 a barrel
to its highest levels since March as a third promising
coronavirus vaccine raised hope for fuel demand recovery and
U.S. President-elect Joe Biden began his transition to the White
House.
Brent crude LCOc1 rose $1.65, or 3.6%, to $47.22 a barrel
by 11:34 a.m. EST (1634 GMT), to $47.71 a barrel. U.S. West
Texas Intermediate crude CLc1 gained $1.89, or 4.4%, to $44.95
a barrel. Both benchmarks reached their highest since March 6.
AstraZeneca AZN.L on Monday said that its COVID-19 vaccine
was 70% effective in trials and could be up to 90% effective,
giving the fight against the pandemic another potential vaccine
after positive results from Pfizer-BioNTech PFE.N 22UAy.DE
and Moderna MRNA.O .
"The possibility of having a vaccine next year increases the
odds that we're going to see demand return in the new year,"
said Phil Flynn, senior analyst at Price Futures Group in
Chicago.
The coronavirus pandemic, coupled with the collapse of an
OPEC-led output pact, sent prices crashing in March.
After the collapse of that output pact led to a brief Saudi
Arabia-Russia price war, the Organization of the Petroleum
Exporting Countries and allies agreed a new deal on record
production cuts to support prices.
The group known as OPEC+ is expected to roll over those cuts
into 2021 after a meeting over Nov. 30 to Dec. 1 following
technical talks this week. In addition, the Trump administration gave Democrat Joseph
Biden access to resources that will enable him to take over in
January after delaying for weeks despite Trump's loss in the
Nov. 3 presidential election. The first of this week's U.S. supply reports is due at 4:30
p.m. EST (2130 GMT) from the American Petroleum Institute.
U.S. crude oil inventories are seen rising slightly last
week, while distillate stockpiles likely declined for the 10th
straight week, an extended Reuters poll showed. EIA/S

<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Brent crude oil prices hit their highest since March as hopes
for a vaccine roll out spur hopes of a recovery in oil demand
https://tmsnrt.rs/398AMKW
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.